Nephi Stella Selected Research

NIR-6T

12/2009

Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nephi Stella Research Topics

Disease

11	Neuroinflammatory Diseases 08/2010 - 08/2003
8	Neoplasms (Cancer) 11/2018 - 08/2007
5	Epilepsy (Aura) 01/2021 - 01/2014
4	Seizures (Absence Seizure) 10/2017 - 01/2014
4	Multiple Sclerosis 01/2015 - 03/2004
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015 - 06/2004
4	Astrocytoma (Pilocytic Astrocytoma) 07/2010 - 08/2007
3	Glioma (Gliomas) 01/2021 - 05/2006
3	Glioblastoma (Glioblastoma Multiforme) 11/2018 - 01/2016
3	Huntington Disease (Huntington's Disease) 11/2014 - 12/2012
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021 - 10/2017
2	Inflammation (Inflammations) 01/2019 - 05/2008
2	Disease Progression 07/2015 - 09/2005
2	Autoimmune Diseases (Autoimmune Disease) 10/2014 - 05/2011
2	Brain Injuries (Brain Injury) 12/2012 - 10/2003
1	Febrile Seizures (Febrile Seizure) 01/2021
1	Hypothermia 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 08/2014
1	Ataxia (Dyssynergia) 12/2013
1	Cataract (Cataracts) 12/2013
1	Polyneuropathies (Polyneuropathy) 12/2013
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 12/2013
1	Hearing Loss (Hearing Impairment) 12/2013
1	Weight Loss (Weight Reduction) 12/2012
1	Chronic Pain 05/2011
1	Movement Disorders (Movement Disorder) 02/2010
1	Pain (Aches) 06/2009
1	Body Weight (Weight, Body) 02/2009
1	Brain Neoplasms (Brain Tumor) 08/2007
1	Breast Neoplasms (Breast Cancer) 05/2006
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2006
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2004

Drug/Important Bio-Agent (IBA)

17	CannabinoidsIBA 01/2019 - 03/2004
11	EndocannabinoidsIBA 01/2019 - 08/2003
7	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2017 - 04/2006
3	CannabidiolIBA 01/2021 - 01/2017
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 02/2015 - 01/2014
3	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 08/2010 - 09/2004
3	Proteins (Proteins, Gene)FDA Link 12/2009 - 05/2006
3	LipidsIBA 06/2009 - 10/2003
2	Voltage-Gated Sodium ChannelsIBA 01/2021 - 10/2017
2	HydrolasesIBA 01/2019 - 12/2013
2	Dronabinol (THC)FDA LinkGeneric 01/2019 - 01/2009
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 01/2016
2	Muscarinic AgonistsIBA 02/2015 - 01/2014
2	Pilocarpine (Ocusert)FDA LinkGeneric 02/2015 - 01/2014
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 02/2015 - 01/2014
2	Neuropeptide YIBA 07/2014 - 02/2013
2	anandamide (arachidonylethanolamide)IBA 02/2008 - 10/2003
1	Clonazepam (Rivotril)FDA LinkGeneric 01/2021
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	GelatinIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	CarbazolesIBA 11/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	indoleIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2016
1	Biological ProductsIBA 07/2015
1	OrganophosphatesIBA 02/2015
1	Paraoxon (E600)IBA 02/2015
1	Muscarinic M1 ReceptorIBA 02/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Huntingtin ProteinIBA 11/2014
1	polyglutamineIBA 11/2014
1	Growth Factor ReceptorsIBA 08/2014
1	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 08/2014
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014
1	Neutralizing AntibodiesIBA 12/2012
1	Interleukin-6 (Interleukin 6)IBA 12/2012
1	NIR-mbc94IBA 05/2011
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 02/2010
1	NIR-conPKIBA 12/2009
1	IRDye 800CWIBA 12/2009
1	PK 11195 (PK11195)IBA 12/2009
1	NIR-6TIBA 12/2009
1	DAA 1106IBA 12/2009
1	CytokinesIBA 12/2009
1	alpha-SynucleinIBA 06/2009
1	Cannabinoid Receptor AntagonistsIBA 02/2009
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 02/2009
1	(4- amino- 1- (4- chlorobenzyl)- 2- methyl- 5- phenyl- 1H- pyrrol- 3- yl)(phenyl)methanoneIBA 02/2009
1	Indicators and Reagents (Reagents)IBA 05/2008
1	N-acylethanolaminesIBA 02/2008
1	EnzymesIBA 01/2008
1	CannabinolIBA 09/2005
1	Adenosine Triphosphate (ATP)IBA 09/2004
1	OxidesIBA 06/2004
1	NeuropeptidesIBA 10/2003
1	Endothelin-1 (Endothelin 1)IBA 10/2003

Therapy/Procedure

10	Therapeutics 01/2021 - 08/2003
1	Radiotherapy 01/2021
1	Lasers (Laser) 12/2012
1	Immunomodulation 06/2009